BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2841991)

  • 1. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate.
    Bell D; Millar AM; Grayshan R; Muir AL
    Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991
    [No Abstract]   [Full Text] [Related]  

  • 2. 99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental myocardial infarction in dogs.
    Duska F; Hadas L; Vizda J; Kafka P; Urbanová E; Palicka V; Mazurová Y; Kuba M; Grossman V
    Nuklearmedizin; 1988 Oct; 27(5):226-7. PubMed ID: 2848225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
    Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
    J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates.
    Logic JR; Meyer-Pavel CM; Blackman J
    J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of positive myocardial imaging.
    Hale TI; Jucker A
    Eur J Nucl Med; 1984; 9(11):525-6. PubMed ID: 6097450
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comparison of the gluconate and pyrophosphate heart scan in the diagnosis of acute transmural myocardial infarctions].
    Duska F; Kubícek J; Novák J; Vizdá J; Kafka P; Bastecký J
    Cesk Radiol; 1982 Nov; 36(6):402-9. PubMed ID: 6297812
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of acute myocardial infarcts by infarct-avid imaging.
    Willerson JT
    J Nucl Med; 1991 Feb; 32(2):269-71. PubMed ID: 1846912
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Tc-99m pyrosphosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication.
    Wakat MA; Chilton HM; Hackshaw BT; Cowan RJ; Ball JD; Watson NE
    J Nucl Med; 1980 Mar; 21(3):203-6. PubMed ID: 6245193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myocardial infarction delineated by noninvasive thallium-201/technetium-99m pyrophosphate tomography.
    Krause T; Joseph A; Kutzner C; Kasper W; Schuemichen C; Just H; Moser E
    Nucl Med Commun; 1990 Sep; 11(9):617-29. PubMed ID: 2172880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection.
    Willerson JT; Buja LM
    J Am Coll Cardiol; 1991 Feb; 17(2):527-9. PubMed ID: 1846889
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy].
    Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Sakurai M; Hishida H; Mizuno Y; Takeuchi A; Koga S
    J Cardiogr; 1982 Sep; 12(3):699-708. PubMed ID: 6308105
    [No Abstract]   [Full Text] [Related]  

  • 14. Time course of 99mTc-pyrophosphate and 99mTc-gluconate uptake in experimental ischaemic myocardial necrosis.
    Kasalický J; Riedel A; Konopková M
    Radiobiol Radiother (Berl); 1985; 26(5):641-50. PubMed ID: 3003790
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.
    Takeda K; LaFrance ND; Weisman HF; Wagner HN; Becker LC
    J Am Coll Cardiol; 1991 Feb; 17(2):519-26. PubMed ID: 1846888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of determining the extent of a myocardial infarct].
    Orlov VN; Shilova NA
    Sov Med; 1983; (1):52-5. PubMed ID: 6301075
    [No Abstract]   [Full Text] [Related]  

  • 17. Infarct sizing with Tc-99m pyrophosphate.
    Bianco JA
    J Nucl Med; 1982 Oct; 23(10):939-40. PubMed ID: 6288900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Scintigraphic findings in myocardial infarct].
    Schümichen C; Krause T
    Radiologe; 1988 Sep; 28(9):409-16. PubMed ID: 2847229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
    Singh A; Usher M
    J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging.
    Tamaki N; Yamada T; Matsumori A; Yoshida A; Fujita T; Ohtani H; Watanabe Y; Yonekura Y; Endo K; Konishi J
    J Nucl Med; 1990 Feb; 31(2):136-42. PubMed ID: 2156026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.